Researchers continue to excited about this new drug, a groundbreaking dual treatment showing promising results in early trials for weight loss . It functions by targeting two pathways : GLP-1 and GIP, https://hassanbhvz422907.angelinsblog.com/39619173/this-new-prospect-for-body-reduction